PUBLIC COMPANY
save$AAPGASCENTAGE PHARMA GROUP INTERNATIONAL
$AAPG18.20-4.13%Suzhou , Jiangsu, CNupdated 13h ago
community read0 votes
pipeline
7
marketed
0
phase 3
2
catalysts ytd
1
approvals ytd
0
recalls ytd
0
Pipeline(7)
pipeline depth7 products
2Preclinical1Phase 12Phase 22Phase 3
Phase 3
lisaftoclax
Myelodysplastic Syndrome (Preleukemia)
Phase 3olverembatinib
Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leuk…
Bcr/Abl fusion protein
Phase 2alrizomadlin
Lung Adenocarcinoma
Phase 2pelcitoclax
Neuroendocrine Tumors
Phase 1APG-5918
Castration-Resistant Prostate Cancer (CRPC)
PreclinicalAPG-3526
Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia)
PreclinicalAS-00491
Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia)
Upcoming
Recent(90d)
nothing in the last 90 days
view all catalysts →Active trials
- phase1A Study of APG-3288 in Relapsed/Refractory Blood Cancers
- phase1A Study to Evaluate the Safety, Pharmacokinetics and Preliminary Efficacy of APG-5918.
- phase1A Study of HQP1351 in Patients With GIST or Other Solid Tumors
- phase2Study of APG-2575 in Patients With Relapsed/Refractory CLL/SLL
- phase2APG-1387 Plus Chemotherapy in Advanced Pancreatic Adenocarcinoma
- phase2Dose-escalation Study of APG-1387 and Toripalimab in Solid Tumors
- phase1Pharmacokinetics of Olverembatinib in Participants With Hepatic Impairment
- phase2A Study of APG-2575 in Patients With Mild-to-moderate Systemic Lupus Erythematosus.
Insider activity
source: SEC Form 4routine RSU / option mechanics (1)
- Apr 20, 26grantMisra Veet · Chief Financial Officer18,584 sh
🐶 Hiring Signal
next earnings Aug 19, 2026
News
no news has mentioned this company yet
Data sources
last refreshed 1m ago
Found something off?
comments(0)
5-min edit window · permanent after that